Clinical Study
Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation
Table 3
Ventricular activation times acquired under the different AVD values tested.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values represent means ± SD. AVD, atrioventricular delay; echo, echocardiographic mapping; ECM, electrocardiographic mapping; TVaT, total ventricular activation Time; VaT10-90, ventricular activation time10-90. Values were compared by ANOVA and the Kruskal–Wallis test. No between-group comparisons were significant (Tukey’s HSD). |